Presentations & Publications
2020
- Lower success rate of débridement and implant retention in late acute versus early acute periprosthetic joint infection caused by Staphylococcus spp. results from a matched cohort study.
Wouthuyzen-Bakker M, Sebillotte M, Huotari K, ESCMID Study Group for Implant-Associated Infections (ESGIAI), et al. Clin Orthop Relat Res 2020. doi: 10.1097/CORR.0000000000001171. - Propionibacterium/Cutibacterium species-related positive samples, identification, clinical and resistance features: a 10-year survey in a French hospital.
Broly M, Ruffier d'Epenoux L, Guillouzouic A, et al. Eur J Clin Microbiol Infect Dis 2020; 39:1357-1364. doi: 10.1007/s10096-020-03852-5. - How to handle concomitant asymptomatic prosthetic joints during an episode of hematogenous PJI, a multicentre analysis.
Wouthuyzen-Bakker M, Sebillotte M, Arvieux C et al. Clin Infect Dis 2020; ciaa1222. doi: 10.1093/cid/ciaa1222. - The impact of surgical strategy and rifampin on treatment outcome in Cutibacterium periprosthetic joint infections.
Achermann Y, Kusejko K, Auñón A et al. Clin Infect Dis 2020; ciaa1839. doi: 10.1093/cid/ciaa1839. - 2020 Frank Stinchfield Award: Identifying who will fail following irrigation and debridement for prosthetic joint infection.
Shohat N, Goswami K, Tan T L et al. Bone Joint J 2020; 102-B:11–19. doi:10.1302/0301-620x.102b7.bjj-2019-1628.r1.
2019
- Suppressive antibiotic therapy in prosthetic joint infections: a multicentre cohort study.
Escudero-Sanchez R, Senneville E, Digumber M, et al. Clin Microbiol Infect 2019. pii: S1198-743X(19)30492-6. doi: 10.1016/jcmi2019.09.007. - Multidrug-resistant and extensively drug-resistant Gram-negative prosthetic
joint infections: Role of surgery and impact of colistin administration.
Papadopoulos A, Ribera A, Mavrogenis AF, et al. Int J Antimicrob Agents 2019;53:294-301. doi: 10.1016/j.ijantimicag.2018.10.018 - Corrigendum to "Multidrug-resistant and extensively drug-resistant Gram-negative
prosthetic joint infections: Role of surgery and impact of colistin administration"
Papadopoulos A, Ribera A, Mavrogenis AF, et al. Int J Antimicrob Agents 2019;S0924-8579(19)30058-5. doi: 10.1016/j.ijantimicag.2019.03.005. - Clinical outcome and risk factors for failure in late acute prosthetic joint
infections treated with debridement and implant retention.
Wouthuyzen-Bakker M, Sebillotte M, Lomas J, et al. J Infect 2019;78:40-47. doi: 10.1016/j.jinf.2018.07.014. - Timing of implant-removal in late acute periprosthetic joint infection: A multicenter observational study.
Wouthuyzen-Bakker M, Sebillotte M, Lomas J, et al, J Infect 2019;79:199-205. doi: 10.1016/j.jinf.2019.07.003. - Antibiotic Use in Total Knee Arthroplasty Periprosthetic Joint Infection.
Wouthuyzen-Bakker M, Lora-Tamayo J, Soriano A; ESCMID Study Group for Implant-associated Infections. Clin Infect Dis 2019 pii: ciz631. doi: 10.1093/cid/ciz631 - Debridement, antibiotics and implant retention is a viable treatment option for early periprosthetic joint infection presenting more than four weeks after index arthroplasty.
Löwik CAM, Parvizi J, Jutte PC et al. Clin Infect Dis 2019. pii: ciz867. doi: 10.1093/cid/ciz867.
CMI Website
eAcademy
EUCAST
